Trial · NCT05817409
Predictive Factors for Succes of ITB in CP
NCT05817409, Not yet recruiting, Amsterdam UMC, location VUmc
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Predictive Factors for Succes of ITB in CP. Trials, record NCT05817409. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05817409
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Predictive Factors for Succes of ITB in CP
- NCT number
- NCT05817409
- Status
- Not yet recruiting
- Enrollment
- 75 participants, estimated
- Lead sponsor
- Amsterdam UMC, location VUmc
- Conditions
- Cerebral Palsy, Intrathecal Baclofen
- Interventions
- Intrathecal Baclofen Pump
- First posted
- 2023-04-18
- Last updated
- 2023-04-18
Source ClinicalTrials.gov
Registered outcomes15
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Goal Attainment Scaling (GAS) | 3 months, 1 year, 2 years | Attainment of personal treatment goals are scored on a standardised scale where -2 is the baseline score and 0 is the goal. Scores can be given for deterioration (-3), improvement but not attainment (-1) and more (+1) or much more (+2) than goal achieved). change in these outcomes between the different time points is assessed. |
| Secondary | range of motion | baseline, 3 months, 1 year, 2 years | range of motion of lower extremity joints |
| Secondary | spasticity | baseline, 3 months, 1 year, 2 years | Catch present or not |
| Secondary | Barry-Albright-Dystonia Scale (BADS) | baseline, 3 months, 1 year, 2 years | Dystonia is assessed in 8 body regions. A score of 0 to 4 can be given, where 0 represents no dystonia present, and 4 represents severe dystonia present. |
| Secondary | Scoliosis | baseline, 3 months, 1 year, 2 years | Cobb angle |
| Secondary | Selective motor control testing | baseline, 3 months, 1 year, 2 years | Selective control of movement of seperate joints is assessed for the hipflexors, knee-extensors and dorsiflexors of the foot. It is scored as normal, and if a patient can not move one joint seperatly from another joint, selectivity is scored as decreased (some selective control) or absent (no selective control at all) |
| Secondary | Functional strength testing | baseline, 3 months, 1 year, 2 years | Gross motor skills including squatting and toe walking are used to assess the functional strength of muscles. Normal strength testing is difficult in children with central nervous system motor disorders. Scores for the motor skills are: + child is able to execute motor skill, +/- child is able but with problems or incompletly, - child is not able to execute motor skill |
| Secondary | walking pattern/gait analysis | baseline, 3 months, 1 year, 2 years | walking pattern/gait analysis |
| Secondary | Pediatric Evaluation of Disability Inventory (PEDI) | baseline, 3 months, 1 year, 2 years | Questionnaire that assesses functional skilles, level of independence, and the extent of modifications required to perform functional activities in young children |
| Secondary | Caregiver Priorities and Child Health Index of Life with Disabilities (CPCHILD) | baseline, 3 months, 1 year, 2 years | The CPCHILD questionnaire is a validated measure of health-related quality of life for children with severe disabilities. |
1 to 10 of 15Source ClinicalTrials.gov
See all 15 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT05817409
GET https://conductscience.org/api/trials/v1/NCT05817409/registered